Soluble PD-L1 (sPD-L1) in serum, a valuable biomarker in multiple cancers, has been reported, including multiple myeloma (14), renal cell carcinoma (15), B cell lymphoma (16), and malignant melanoma (11, 17). The gene discussed is CD274; the disease is melanoma.